Detalles de la búsqueda
1.
The use of mono- and combination drug therapy in men and women with lower urinary tract symptoms (LUTS) in the UK: a retrospective observational study.
BMC Urol
; 21(1): 119, 2021 Sep 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34474675
2.
Efficacy and Safety of Mirabegron versus Placebo Add-On Therapy in Men with Overactive Bladder Symptoms Receiving Tamsulosin for Underlying Benign Prostatic Hyperplasia: A Randomized, Phase 4 Study (PLUS).
J Urol
; 203(6): 1163-1171, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31895002
3.
Drug utilization patterns and healthcare resource use and costs in patients with neurogenic bladder in the United Kingdom: A retrospective primary care database study.
Neurourol Urodyn
; 38(5): 1278-1289, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30924184
4.
Quality of life in patients aged 65 years and older with overactive bladder treated with mirabegron across eight European countries: Secondary analysis of BELIEVE.
Int J Urol
; 26(9): 890-896, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31302930
5.
Prevalence of metabolic syndrome and its components among men with and without clinical benign prostatic hyperplasia: a large, cross-sectional, UK epidemiological study.
BJU Int
; 117(5): 801-8, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26392030
6.
7.
A Phase 1, open-label, crossover study evaluating the effect of a single dose of sodium zirconium cyclosilicate on the pharmacokinetics of tacrolimus and cyclosporin.
Clin Kidney J
; 16(1): 151-158, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36726439
8.
Anticholinergic Burden and Associated Healthcare Resource Utilization in Older Adults with Overactive Bladder.
Drugs Aging
; 38(10): 911-920, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34386936
9.
Mirabegron Vs Placebo Add-on Therapy in Men With Overactive Bladder Symptoms Receiving Tamsulosin for Underlying Benign Prostatic Hyperplasia: A Safety Analysis From the Randomized, Phase 4 PLUS Study.
Urology
; 147: 235-242, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33045287
10.
Safety and Efficacy of Mirabegron: Analysis of a Large Integrated Clinical Trial Database of Patients with Overactive Bladder Receiving Mirabegron, Antimuscarinics, or Placebo.
Eur Urol
; 77(1): 119-128, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31635815
11.
Mirabegron improves quality-of-life, treatment satisfaction, and persistence in patients with overactive bladder: a multi-center, non-interventional, real-world, 12-month study.
Curr Med Res Opin
; 34(5): 785-793, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29254376
12.
The efficacy of mirabegron in the treatment of urgency and the potential utility of combination therapy.
Ther Adv Urol
; 10(8): 243-256, 2018 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-30034543
13.
Treating Overactive Bladder in Older Patients with a Combination of Mirabegron and Solifenacin: A Prespecified Analysis from the BESIDE Study.
Eur Urol Focus
; 3(6): 629-638, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-28916436
Resultados
1 -
13
de 13
1
Próxima >
>>